VN November 2026

Vetnuus | November 2026 31 ABSTRACT The effect of a high-fat diet (HFD) on the progression of cardiomyopathy and nephropathy. Diabetes mellitus was identified as a chronic metabolic disorder characterised by persistent hyperglycemia, which contributed to severe complications such as cardiomyopathy and nephropathy. High-fat diet intake further aggravated metabolic imbalances, thereby accelerating the progression of these systemic complications. The present study evaluated cardiac and renal functions in Wistar rats fed an HFD following streptozotocin (STZ)-induced diabetes. Diabetes was induced using STZ (40 mg kg-1, i.p.) in HFD-fed rats, and animals with blood glucose levels exceeding 300 mg dl-1 four days postinduction were considered diabetic. Diabetic animals were compared with normal rats to assess metabolic, renal, and cardiac alterations. Body weight, blood glucose, total cholesterol, triglycerides, blood urea nitrogen (BUN), creatinine, and creatine kinase-myoglobin binding (CK-MB) were assessed at baseline, pre-induction, and on days 1, 14, and 28. Diabetic rats on HFD showed persistent hyperglycemia, progressive weight loss, and severe dyslipidemia. Elevated renal markers, specifically BUN and creatinine, and increased CK-MB levels indicated the progression of nephropathy and cardiomyopathy. These results demonstrated that HFD accelerated metabolic disturbances and promoted significant target organ damage in diabetes. The findings highlighted that sustained lipid abnormalities and hyperglycemia synergistically worsened myocardial and renal injury over the experimental period. 1. INTRODUCTION Diabetes mellitus is a collection of metabolic diseases characterised by high blood glucose levels, or hyperglycaemia (Olefsky, 2001). This hyperglycaemia arises from a relative or total lack of insulin secretion, a resistance to the action of insulin, or both of these factors (Babu et al., 2013). According to the International Diabetes Federation, approximately 537 million adults worldwide were living with diabetes in 2021, and this number is projected to rise to 783 million by 2045, highlighting the escalating global health burden. Based on etiopathogenesis, DM is classified into Type 1 and Type 2 diabetes mellitus (Nicolle et al., 2011): type 1, which results from the immune system’s destruction of the body’s own insulin-producing pancreatic cells, and type 2, the more prevalent form, which is characterised by the body’s resistance to insulin in conjunction with an insufficient secretory response (Skyler, 2004). Persistent hyperglycaemia results in progressive macrovascular and microvascular complications, among which diabetic cardiomyopathy and nephropathy are major contributors to diabetes-associated morbidity and mortality (Forbes and Cooper, 2013). The development of diabetic complications is mediated by several interconnected biochemical mechanisms. Chronic hyperglycaemia activates protein kinase C (PKC), enhances flux through the polyol and hexosamine biosynthetic pathways, promotes the accumulation of advanced glycation end-products (AGEs), and increases oxidative stress. These alterations converge to induce endothelial dysfunction, inflammatory signalling, and progressive organ damage (Zhang et al., 2016). Diabetes mellitus is associated with distinct microvascular alterations, including excessive extracellular matrix deposition and thickening of the capillary basement membrane, resulting in diabetic microangiopathy. Persistent hyperglycaemia, along with oxidative stress and inflammation, further contributes to the development of macrovascular complications. Additionally, microvascular injury may aggravate atherosclerotic progression through hypoxia and vasa vasorum dysfunction (Chawla et al., 2016). Advanced glycation end-products (AGEs) have been implicated in the progression of chronic kidney disease in diabetes. Their reactive precursor, methylglyoxal, has been shown to accelerate renal injury, particularly under conditions of reduced glyoxalase-1 activity. Furthermore, AGEs may aggravate diabetic nephropathy by upregulating angiotensinogen expression, thereby contributing to renal dysfunction (Parveen et al., 2021). Chronic hyperglycaemia in diabetes induces microvascular alterations, oxidative stress, inflammation, impairment of the IRS–PI3K/Akt signalling pathway leading to insulin resistance, and accumulation of advanced glycation end-products and methylglyoxal under reduced glyoxalase-1 activity, collectively accelerating renal injury, angiotensinogen expression, and the progression of diabetic nephropathy and cardiovascular complications (Guo, 2014). Consumption of a high-fat diet (HFD) plays a pivotal role in the development of Type 2 diabetes by promoting insulin resistance, dyslipidaemia, and metabolic stress (Lozano et al., 2016). The combination of a high-fat diet (HFD) and low-dose streptozotocin (STZ) induces diabetic complications in rats, characterised by micro- and macrovascular lesions, renal injury, and pathological features that resemble human diabetic nephropathy and vascular abnormalities (Rather et al., 2023). Effect of High-Fat Diet (HFD) on Progression of Cardiomyopathy and Nephropathy Aruna B.1, Sujith S.1, Sanis Juliet1, Ranjith D.1, Pradeep M.2, Divya P. D.3, Adheena Xavier1, Bindu Shree R.1, Ananthu Vijayakrishnan1 and Deepanjaly S.1 1Dept. of Veterinary Pharmacology and Toxicology, 2Dept. of Veterinary Pathology, 3Dept. of Veterinary Biochemistry, College of Veterinary and Animal Sciences, Pookode, Kerala Veterinary and Animal Sciences University, Wayanad, Kerala (673 576), India Article >>>32

RkJQdWJsaXNoZXIy OTc5MDU=